Nanjie Xiao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center

发表论文 19 篇 · 总被引 486 次 · h-index 6

代表论文

• COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma (2022 · Journal of Hepatology · 被引 251)
• EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan (2015 · Medical Oncology · 被引 76)
• A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN) (2016 · Oncotarget · 被引 60)
• A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC) (2016 · Oncotarget · 被引 51)
• COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma (2021 · Clinical and Translational Medicine · 被引 23)
• Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee (2021 · Medicine · 被引 6)